What is the maximum recommended dose of cyclosporine (CsA) for a patient with psoriasis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: July 18, 2025 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Maximum Dose of Cyclosporine for Psoriasis

The maximum recommended dose of cyclosporine for psoriasis is 5 mg/kg/day, with treatment duration typically limited to 12-16 weeks for initial courses and up to 1 year for total cumulative treatment. 1, 2

Dosing Regimen

There are two main approaches to cyclosporine dosing in psoriasis:

  1. Starting at intermediate dose and titrating up:

    • Begin with 2.5-3.0 mg/kg/day divided into two daily doses
    • Maintain this dose for approximately 4 weeks
    • If needed, increase by increments of 0.5 mg/kg/day until disease control is achieved
    • Maximum dose: 5 mg/kg/day 1, 3
  2. Starting at maximum dose and tapering down:

    • Begin with 5 mg/kg/day (for more severe disease)
    • After adequate disease control is achieved, implement stepwise decreases
    • Gradually reduce to the lowest effective maintenance dose 3

Efficacy Based on Dosing

  • 5 mg/kg/day: Produces PASI 75 response in 50-97% of patients 1, 4
  • 3 mg/kg/day: Achieves PASI 75 in 50-70% and PASI 90 in 30-50% of patients 1
  • 2.5 mg/kg/day: Achieves PASI 75 in 28-85% of patients 1, 4

Administration Guidelines

  • Administer at a consistent time of day and in relation to meals to decrease blood level variations
  • Can be mixed with milk, orange juice, or apple juice (avoid grapefruit juice as it increases cyclosporine concentrations) 2
  • For maintenance therapy, 3 mg/kg/day has been shown to adequately maintain remission in 58% of patients for 6 months 5

Monitoring and Dose Adjustments

  • Monitor serum creatinine monthly
  • If serum creatinine increases >25% above baseline on two occasions (separated by 2 weeks):
    • Reduce dose by 25-50%
    • Follow creatinine every other week for 1 month
    • If creatinine doesn't decrease to within 25% of baseline, reduce dose by another 25-50%
    • If creatinine remains >25% above baseline after these adjustments, discontinue cyclosporine 3

Duration of Treatment

  • Short-term treatment (12-16 weeks) is preferred for initial courses 1
  • Continuous treatment beyond 1 year is not recommended due to increased risk of nephrotoxicity 2
  • Intermittent short courses are preferred over continuous long-term therapy 3

Important Cautions

  • Nephrotoxicity risk: 19-24% develop reversible nephrotoxicity during short-term treatment; >50% of patients treated for >2 years may experience creatinine increases >30% above baseline 1, 4
  • Age-related risk: Patients >45 years have higher risk of hypertension and renal function changes 6
  • Drug interactions: Avoid concomitant use with aminoglycosides, amphotericin, trimethoprim, ketoconazole, phenytoin, rifampicin, isoniazid, and NSAIDs 7
  • Contraindications: Simultaneous administration with NB-UVB phototherapy is contraindicated due to increased photocarcinogenesis risk 1

Common Pitfalls to Avoid

  1. Exceeding maximum dose: Never exceed 5 mg/kg/day, even in severe cases
  2. Prolonged continuous treatment: Avoid continuous treatment beyond 1 year
  3. Inadequate monitoring: Regular monitoring of blood pressure and renal function is essential
  4. Ignoring drug interactions: Always review medication lists before initiating therapy
  5. Abrupt discontinuation: Consider gradual tapering to minimize risk of rebound

By following these guidelines, you can maximize the efficacy of cyclosporine while minimizing its potential toxicity in patients with psoriasis.

Related Questions

What is the maximum dose of cyclosporine (cyclosporin) for a patient with psoriasis, particularly in cases of morbid obesity, and should the dose be calculated based on actual weight or ideal body weight, even for patients weighing over 70 kilograms (kg)?
What is the maximum recommended dose of cyclosporine (Cyclosporin) for an adult patient?
What is the appropriate cyclosporine regimen for a 70‑kg adult with psoriasis, including starting dose, titration, monitoring parameters, contraindications, and alternative treatment options?
What is the recommended dose and treatment duration of doxycycline (DOXY) for psoriasis?
What are the pharmacology and oral administration recommendations for cyclosporine?
What is the recommended dosage and use of Dexilant (dexlansoprazole) for treating gastroesophageal reflux disease (GERD) and erosive esophagitis?
What is the difference between amlodipine (calcium channel blocker) and nicardipine (calcium channel blocker) in the management of hypertension?
What is the technique for a thoracic transforaminal epidural injection?
What is the maximum dose of cyclosporine (cyclosporin) for a patient with psoriasis, particularly in cases of morbid obesity, and should the dose be calculated based on actual weight or ideal body weight, even for patients weighing over 70 kilograms (kg)?
What does the EBV (Epstein-Barr Virus) Ab (Antibody)/EA (Early Antigen) IgG (Immunoglobulin G) test detect?
What does VCA (Viral Capsid Antigen) stand for in EBV (Epstein-Barr Virus) Ab/VCA IgG?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.